Profil
Axel Zander has held the title of Vice President & Director at SymbioCellTech LLC since 2006 and is the founder of the company in the same year.
He was also the founder of AlloCure, Inc. in 2008, where he held the title of Chief Scientific Officer.
Postes actifs de Axel Zander
| Sociétés | Poste | Début |
|---|---|---|
SymbioCellTech LLC
 SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Fondateur | 01/01/2006 |
Anciens postes connus de Axel Zander
| Sociétés | Poste | Fin |
|---|---|---|
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Health Technology |
SymbioCellTech LLC
SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Health Technology |
